| Company Name: |
Suzhou Meishi Biotechnology Co., Ltd.
|
| Tel: |
1173954148q |
| Email: |
meishipharma@126.com |
| Products Intro: |
Product Name:162819-83-2
CAS:162819-83-2
Purity:99% HPLC Package:1G;5G;10G;100G;1KG;
|
|
| | 162819-83-2 Basic information |
| Product Name: | 162819-83-2 | | Synonyms: | 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(N-methylbenzylamino)morphinan;Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-[methyl(phenylmethyl)amino]-, (5α,6β)- | | CAS: | 162819-83-2 | | MF: | C28H34N2O3 | | MW: | 446.59 | | EINECS: | | | Product Categories: | | | Mol File: | 162819-83-2.mol |  |
| | 162819-83-2 Chemical Properties |
| Boiling point | 612.0±55.0 °C(Predicted) | | density | 1.34±0.1 g/cm3(Predicted) | | pka | 9.43±0.60(Predicted) |
| | 162819-83-2 Usage And Synthesis |
| Uses | 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(N-methylbenzylamino)morphinan is an impurity of Nalfurafine (N255600), the first in class non-narcotic opioid drug for intractable itch caused by hemodialysis. It showed significant opioid κ-agonist activity and induced neither aversion nor preference in rats on the CPP (Conditioned Place Preference) test. |
| | 162819-83-2 Preparation Products And Raw materials |
|